Dopamine, extrapyramidal system, and psychomotor function.
D000661:Amphetamine / Q000494:pharmacology; D000818:Animals; D001479:Basal Ganglia / Q000502:physiology; D002090:Butyrophenones / Q000494:pharmacology; D002421:Caudate Nucleus / Q000502:physiology / Q000503:physiopathology; D003342:Corpus Striatum / Q000502:physiology; D004295:Dihydroxyphenylalanine / Q000494:pharmacology; D004298:Dopamine / Q000502:physiology*; D005116:Extrapyramidal Tracts / Q000502:physiology*; D000882:Haplorhini; D006801:Humans; D008781:Methyltyrosines / Q000494:pharmacology; D009043:Motor Activity; D010300:Parkinson Disease / Q000209:etiology; D010640:Phenothiazines / Q000494:pharmacology; D010648:Phenylacetates / Q000134:cerebrospinal fluid; D011596:Psychomotor Disorders / Q000139:chemically induced; D011603:Psychophysiology; D012110:Reserpine / Q000009:adverse effects; D013681:Tegmentum Mesencephali / Q000502:physiology; D013787:Thalamic Nuclei / Q000502:physiology; D013788:Thalamus / Q000502:physiology; D014202:Tremor / Q000209:etiology
D002090:Butyrophenones; D008781:Methyltyrosines; D010640:Phenothiazines; D010648:Phenylacetates; D004295:Dihydroxyphenylalanine; D012110:Reserpine; D000661:Amphetamine; D004298:Dopamine